Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients

Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients

Kenji Yoshimura, Ryoji Maekura, Toru Hiraga, Seigo Kitada, Keisuke Miki, Mari Miki, Yoshitaka TateishiDepartment of Respiratory Medicine, Toneyama National Hospital, Osaka, JapanBackground: Tiotropium partially relieves exertional dyspnea and reduces the risk of congestive heart failure in chronic o...

Full description

Bibliographic Details
Main Authors:	Kitada S, Hiraga T, Maekura R, Yoshimura K, Tateishi Y, Miki M, Miki K
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-05-01
Series:	International Journal of COPD
Online Access:	http://www.dovepress.com/effects-of-tiotropium-on-sympathetic-activation-during-exercise-in-sta-a9801

Similar Items

Clinical Effects Of Acupuncture On The Pathophysiological Mechanism Of Chronic Obstructive Pulmonary Disease During Exercise
by: Maekura T, et al.
Published: (2019-12-01)

Dyspnea and the Varying Pathophysiologic Manifestations of Chronic Obstructive Pulmonary Disease Evaluated by Cardiopulmonary Exercise Testing With Arterial Blood Analysis
by: Hiroyuki Kagawa, et al.
Published: (2018-10-01)

Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial.
by: Keisuke Miki, et al.
Published: (2012-01-01)

Pulmonary rehabilitation for COPD improves exercise time rather than exercise tolerance: effects and mechanisms
by: Miki K, et al.
Published: (2017-04-01)

Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease
by: Ryoji Maekura, et al.
Published: (2022-06-01)

Increased Oxygen Extraction by Pulmonary Rehabilitation Improves Exercise Tolerance and Ventilatory Efficiency in Advanced Chronic Obstructive Pulmonary Disease
by: Akito Miyazaki, et al.
Published: (2022-02-01)

Tiotropium bromide: role in the treatment of chronic obstructive pulmonary disease
by: A I Sinopalnikov
Published: (2004-03-01)

Tiotropium in chronic obstructive pulmonary disease – a review of clinical development
by: Antonio Anzueto, et al.
Published: (2020-07-01)

Changes in functional status and inflammation profile in patients with chronic obstructive pulmonary disease during therapy with tiotropium
by: I. N. Trofimenko, et al.
Published: (2015-12-01)

The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator.
by: Neyt, M, et al.
Published: (2012)

The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator
by: Neyt, M, et al.
Published: (2012)

Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease
by: Shalini Naik, et al.
Published: (2010-03-01)

Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease
by: Halpern R, et al.
Published: (2011-07-01)

Oxygen Extraction Based on Inspiratory and Expiratory Gas Analysis Identifies Ventilatory Inefficiency in Chronic Obstructive Pulmonary Disease
by: Keisuke Miki, et al.
Published: (2021-07-01)

Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
by: Ramadan WH, et al.
Published: (2015-10-01)

Direct Switch from Tiotropium to Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease Patients in Korea
by: Sang Haak Lee, et al.
Published: (2021-04-01)

Exercise-Induced Modulation of Baroreflex Control of Sympathetic Nerve Activity
by: Kenju Miki, et al.
Published: (2018-07-01)

Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease
by: Bai C, et al.
Published: (2017-11-01)

The Efficacy and Cost-Effectiveness of Umeclidinium/Vilanterol versus Tiotropium in Symptomatic Patients with Chronic Obstructive Pulmonary Disease
by: Yinhua Gong, et al.
Published: (2022-01-01)

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease
by: Miravitlles M, et al.
Published: (2015-03-01)

Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
by: Nalini Jayanthi, et al.
Published: (2022-08-01)

Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium
by: Beeh Kai-Michael, et al.
Published: (2012-06-01)

Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease
by: François Maltais, et al.
Published: (2018-02-01)

Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease
by: Inui N, et al.
Published: (2015-06-01)

Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective
by: Dhvani Shah, et al.
Published: (2018-05-01)

Legal demands of the tiotropium bromide for treatment of chronic obstructive pulmonary disease and their financial impact for the State of Paraná, Brazil
by: Renata Szpak, et al.

Sequential comparison of tiotropium to high-dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting
by: Umair Gauhar, et al.
Published: (2009-10-01)

A randomized multicenter Phase II study of perioperative tiotropium intervention in gastric cancer patients with chronic obstructive pulmonary disease
by: Fushida S, et al.
Published: (2015-10-01)

Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease
by: Takahashi K, et al.
Published: (2021-12-01)

Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity
by: Ichinose M, et al.
Published: (2018-05-01)

Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK
by: Eklund O, et al.
Published: (2016-06-01)

Total Antioxidant Status in Stable Chronic Obstructive Pulmonary Disease
by: Hlavati M, et al.
Published: (2020-10-01)

Intolerance to and limitations of inspiratory muscle training in patients with advanced chronic obstructive pulmonary disease: A report of two cases
by: Yuji Yamamoto, et al.
Published: (2020-01-01)

Tiotropium and exercise training in COPD patients: Effects on dyspnea and exercise tolerance
by: Nicolino Ambrosino, et al.
Published: (2008-10-01)

Bibliometric Analysis of Exercise and Chronic Obstructive Pulmonary Disease
by: Chen M, et al.
Published: (2023-06-01)

Effects of pulmonary-based Qigong exercise in stable patients with chronic obstructive pulmonary disease: a randomized controlled trial
by: Linhong Jiang, et al.
Published: (2023-11-01)

Pharmacological therapy for stable chronic obstructive pulmonary disease
by: Ruirui Duan, et al.
Published: (2023-06-01)

Breathing pattern and thoracoabdominal motion during exercise in chronic obstructive pulmonary disease
by: G.S. Alves, et al.
Published: (2008-11-01)

The effect of acute magnesium loading on the maximal exercise performance of stable chronic obstructive pulmonary disease patients
by: Angélica Florípedes do Amaral, et al.
Published: (2012-01-01)

Pharmacoeconomic analysis of the use of a fixed combination of tiotropium bromide and olodaterol as maintenance therapy in patients with chronic obstructive pulmonary disease in the Russian Federation
by: S. К. Zyryanov, et al.
Published: (2022-07-01)